Tuesday, 19 October, 2021

HC issues contempt rule against health secretary, DGHS DG, 3 others

  • Sun Online Desk
  • 11th August, 2021 05:45:11 PM
  • Print news
HC issues contempt rule against health secretary, DGHS DG, 3 others

The High Court has issued a rule against Health Secretary Lokman Hossain Mia and Director General of Directorate General of Health Service Dr Abul Basar Mohammad Khurshid and three others asking them to explain why they shall not be punished for contempt of court.

They are facing the rule for disobeying February 13, 2017 verdict of the HC which asked them to stop production of harmful antibiotic medicine by Indo-Bangla Pharmaceuticals in Barisal without following Good Manufacturing Practice (GMP).

Three others officials facing contempt rule are- Director General of Department of Consumer Protection Bablu Kumar Shah, Director General of Drug Administration Major General Mahbubur Rahman and managing director of Indo-Bangla Pharmaceuticals Anwarul Haque.

A division bench comprising Justice Mamnoon Rahman and Justice Khandaker Diliruzzaman issued the contempt rule following a petition filed by Human Rights and Peace for Bangladesh (HRPB).

The contemnors will have to submit reply to the rule of the High Court within four weeks.

Appearing for petitioner, Supreme Court lawyer and HRPB president Manzill Murshid said antibiotics are a life-saving medicine. But Indo Bangla Pharmaceuticals is producing antibiotics without following GMP and marketing those.

Drug Administration and other authorities are not taking any action against the company ignoring the apex court order and committing punishable offence.

On 13 February, 2017, The High Court passed an order directing the government to halt complete production of 20 pharmaceutical companies and production of antibiotics, following a writ petition filed by HRPB.

The 20 companies are- Avert Pharma, Bikalpa Pharmaceutical, Dolphin Pharmaceuticals, Drugland, Exim Pharmaceutical, Globe Laboratories, Jalpa Laboratories and Kafina Pharmaceuticals, Medico Pharmaceutical, National Drug, North Bengal Pharmaceutical, Rimo Chemical, Rid Pharmaceutical, Skylab Pharmaceutical, Spark Pharmaceutical, Star Pharmaceutical, Sunipun Pharmaceutical, Today Pharmaceutical, Tropical Pharmaceutical and Universal Pharmaceutical.

Talking to Daily Sun, Manzill Murshid said “Indo-Bangla Pharmaceuticals continues to produce the antibiotics although other companies reportedly stopped production. Indo-Bangla Pharmaceuticals is producing the antibiotics without following GMP. If chemicals and ingredients of the medicine are not preserved in the proper temperature and environment, those change their characters and become harmful for human body.”